Solventum Corporation
SOLV Healthcare Medical Instruments & Supplies
Solventum Corporation’s revenue for fiscal 2025 (year ended December 2025) was $8.3 billion, up 0.86% from fiscal 2024. In the quarter to June 2026, revenue grew 2.22%, EPS grew 1.92%, free cash flow grew 144.1% and total debt fell 32.4%, each against the same quarter a year earlier. Member of the S&P 500; revenue growth for three consecutive years; insiders bought in the last twelve months.
Follow SOLV
Solventum Corporation (SOLV) Return on equity
Solventum Corporation's return on equity over the twelve months to 30 June 2026 was 34.0%, down 4.9 percentage points from fiscal 2025 (38.9%). That is above the Medical Instruments & Supplies industry median of −1.32% and above the Healthcare sector median of −31.3%.
Return on equity, annual
Embed this chart
Annual newest first
| Period | Return on equity | Change (points) |
|---|---|---|
| FY2025 | 38.9% | 32.31 |
| FY2024 | 6.55% | 6.55 |
| FY2023 | 0.00% | 0.00 |
| FY2022 | 0.00% | — |
Return on equity against peers
| Company | Return on equity |
|---|---|
| SOLV Solventum Corporation | 34.0% |
| WST West Pharmaceutical Services, Inc. compare | 19.1% |
| ATR AptarGroup, Inc. compare | 13.5% |
| ALGN Align Technology, Inc. compare | 10.2% |
| COO The Cooper Companies, Inc. compare | 6.84% |
| ALC Alcon compare | 2.94% |
| RGEN Repligen Corporation compare | 1.99% |
| AVTR Avantor, Inc. compare | −9.70% |
| BAX Baxter International Inc. compare | −15.8% |
| Medical Instruments & Supplies industry median | −1.32% |
| Healthcare sector median | −31.3% |
| Market median | 1.35% |
What Return on equity is
ROE shows how much profit a company earns for its shareholders on the equity they have in the business.
Annual: Net Income Allotted to Shareholders ÷ Average Common Equity; TTM: Net Income Allotted to Shareholders ÷ Average Common Equity (latest quarter)
More on SOLV
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Shares outstanding
- Book value per share
- Revenue growth
- The full statement